Five Principles For Building Successful Digital Partnerships

In the first of a new series of exclusive columns from senior thought leaders at Deloitte, Roland Foxcroft shares his view on how to build partnerships with digital leaders to create mobile apps that satisfy all stakeholders.

Smart Phone

Investment in digital health is growing rapidly and has cumulatively reached $15.5bn in the US alone. However, much of this growth has been characterized by fragmentation for pharmaceutical companies. Despite iOS and Android hosting over 165,000 health apps, more than 48% of pharmaceutical company published apps do not have a single user review. It is little wonder, therefore, that a recent study has highlighted that only 13% of pharmaceutical leaders are satisfied with their current digital activities.

Currently, 82% of mobile apps have just one or two functions which only allow them to support one specific part of the pharmaceutical value chain. However, digital technology, when properly...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

Sanofi Plays It Safer With Blueprint Buy After Bumpy 2025

 
• By 

But the French major is still keen on early-stage M&A.

BREAKING NEWS: Sanofi Bets $9.5bn To Bag Blueprint

 
• By 

Buy boosts the French major's immunology pipeline.

Quick Listen: Scrip’s Five Must-Know Things

 
• By 

In this week's episode: a preview of major ASCO readouts; Roivant stays patient in deals; Lilly diversifies pain pipeline with SiteOne acquisition; Nucala gets US COPD nod; and women in Indian pharma.

Summit’s Ivonescimab Shows Significance On PFS, But Not Overall Survival

 
• By 

In a study intended to show similar benefit in western patients, PD-1/VEGF-targeting ivonescimab met a progression-free survival endpoint, but missed on OS.

More from Scrip

Public Health And Innovation: Addressing Gaps, Pharma’s Role

 

Expert panel including Ashok Venkitaraman, Director of the Cancer Science Institute of Singapore, discusses public health challenges and innovations to help address these. Long-acting drugs, intercepting cancer early and “design thinking” by ophthalmologists in India were among the talking points.

ASCO: AstraZeneca Changes Management Of Breast Cancer Resistance With SERENA-6

 

AstraZeneca presented data from the SERENA-6 trial that experts said could represent a significant change in how HR+/HER2- breast cancer is treated.

Quick Listen: Scrip’s Five Must-Know Things

 
• By 

In this week's episode: a preview of major ASCO readouts; Roivant stays patient in deals; Lilly diversifies pain pipeline with SiteOne acquisition; Nucala gets US COPD nod; and women in Indian pharma.